secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2022-01-31T23:59:59+00:00
Accession:  0001193125-22-022449
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Candel Therapeutics removes Estuardo Aguilar-Cordova and Laura Aguilar as officers effective Feb 7, 2022
--------------------------------------------------------------------------------

- Estuardo Aguilar-Cordova and Laura Aguilar terminated without cause as officers, effective February 7, 2022.
- Estuardo Aguilar-Cordova will remain on the Board of Directors.
- Both will receive severance as per employment agreements, subject to release of claims.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000119312522022449/0001193125-22-022449-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000119312522022449/d292852d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-022449

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer